Charles River Laboratories Operating Margin 2010-2024 | CRL

Current and historical operating margin for Charles River Laboratories (CRL) over the last 10 years. The current operating profit margin for Charles River Laboratories as of September 30, 2024 is 12.99%.
Charles River Laboratories Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2024-09-30 $4.06B $0.53B 13.00%
2024-06-30 $4.08B $0.56B 13.81%
2024-03-31 $4.11B $0.58B 14.01%
2023-12-31 $4.13B $0.62B 14.97%
2023-09-30 $4.22B $0.65B 15.39%
2023-06-30 $4.18B $0.65B 15.51%
2023-03-31 $4.09B $0.67B 16.38%
2022-12-31 $3.98B $0.65B 16.37%
2022-09-30 $3.78B $0.66B 17.46%
2022-06-30 $3.69B $0.67B 18.03%
2022-03-31 $3.63B $0.62B 16.97%
2021-12-31 $3.54B $0.59B 16.69%
2021-09-30 $3.43B $0.55B 15.96%
2021-06-30 $3.27B $0.52B 16.00%
2021-03-31 $3.04B $0.46B 15.22%
2020-12-31 $2.92B $0.43B 14.81%
2020-09-30 $2.82B $0.41B 14.62%
2020-06-30 $2.75B $0.37B 13.57%
2020-03-31 $2.72B $0.38B 13.80%
2019-12-31 $2.62B $0.35B 13.42%
2019-09-30 $2.53B $0.35B 13.62%
2019-06-30 $2.45B $0.34B 13.71%
2019-03-31 $2.38B $0.33B 14.01%
2018-12-31 $2.27B $0.33B 14.61%
2018-09-30 $2.14B $0.29B 13.63%
2018-06-30 $2.02B $0.28B 13.95%
2018-03-31 $1.91B $0.29B 15.07%
2017-12-31 $1.86B $0.29B 15.56%
2017-09-30 $1.85B $0.30B 15.98%
2017-06-30 $1.81B $0.28B 15.49%
2017-03-31 $1.77B $0.26B 14.44%
2016-12-31 $1.68B $0.24B 14.09%
2016-09-30 $1.57B $0.22B 14.02%
2016-06-30 $1.49B $0.22B 14.48%
2016-03-31 $1.40B $0.21B 15.31%
2015-12-31 $1.36B $0.21B 15.11%
2015-09-30 $1.34B $0.20B 14.56%
2015-06-30 $1.32B $0.19B 14.11%
2015-03-31 $1.32B $0.18B 13.72%
2014-12-31 $1.30B $0.18B 13.71%
2014-09-30 $1.26B $0.16B 12.89%
2014-06-30 $1.22B $0.16B 12.86%
2014-03-31 $1.17B $0.15B 12.70%
2013-12-31 $1.17B $0.15B 13.05%
2013-09-30 $1.16B $0.16B 14.01%
2013-06-30 $1.14B $0.16B 13.91%
2013-03-31 $1.14B $0.17B 14.54%
2012-12-31 $1.13B $0.17B 14.69%
2012-09-30 $1.14B $0.17B 15.16%
2012-06-30 $1.14B $0.17B 15.09%
2012-03-31 $1.14B $0.18B 15.40%
2011-12-31 $1.14B $0.17B 15.22%
2011-09-30 $1.13B $-0.23B -20.55%
2011-06-30 $1.13B $-0.26B -23.43%
2011-03-31 $1.13B $-0.29B -25.44%
2010-12-31 $1.13B $-0.30B -26.37%
2010-09-30 $1.12B $0.10B 9.05%
2010-06-30 $1.14B $0.14B 12.17%
2010-03-31 $1.16B $0.16B 13.78%
2009-12-31 $1.17B $0.17B 14.52%
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00